Day one ready
FY1 · Prescribing
Antimicrobial stewardship and allergy documentation
Prescribing antibiotics with an indication, a duration and a review point — and recording allergy in a way that is actually useful.
Why this matters on day one
Every unnecessary antibiotic day contributes to resistance and to C. difficile. And a vague "penicillin allergy" on a chart, unchallenged, pushes patients onto broader, less effective, more toxic alternatives for the rest of their lives.
The sequence
- 1Start smart. Take cultures before starting where possible. Prescribe according to local policy — not the last thing you saw work. Document indication, route, dose and a STOP or review date on the chart.
- 2Then focus. Review at 48–72 hours against the culture and the clinical response: stop, switch to oral (IVOS), narrow the spectrum, or continue with a documented reason. This review is usually the FY1's job and it is usually skipped.
- 3Document allergy properly. Record the DRUG, the REACTION and the TIMING. "Rash as a child" is not the same as "laryngeal oedema in 2019". Genuine penicillin allergy is far less common than recorded allergy, and true anaphylaxis rarer still.
- 4Interpret cross-reactivity. Non-severe penicillin allergy: most cephalosporins (especially later generations) are acceptable on specialist advice. Severe or anaphylactic penicillin allergy: avoid all beta-lactams unless allergy-tested. Intolerance (nausea, diarrhoea) is NOT an allergy — record it as intolerance so it does not narrow future options.
- 5Protect against C. difficile. Higher risk with broad-spectrum agents, especially in the elderly. New diarrhoea on antibiotics: isolate, send stool, stop the offending antibiotic if possible, and avoid antimotility drugs.
What goes wrong
- No indication and no stop date — the two omissions that make an antibiotic indefinite.
- Never doing the 48-hour review.
- Recording "allergic to lots of things" without detail, permanently restricting the options.
- Treating asymptomatic bacteriuria, especially in catheterised or older patients.
- Reaching for a broad-spectrum agent because the patient is unwell, without a source or a policy.
Escalate when
- Severe or unclear allergy history in someone who needs a beta-lactam → microbiology, and consider allergy referral.
- Failure to respond at 48–72 hours → microbiology advice rather than empirical escalation.
- Suspected multi-resistant organism, or a patient recently treated abroad.
NICE NG15 — antimicrobial stewardship · UK 5-year AMR national action plan · BSACI allergy guidance